{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:33:29Z","timestamp":1791516809521,"version":"4.3.4"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Epigenet. Epigenom."],"abstract":"<jats:p>Early detection is central to reducing cancer related morbidity and mortality, as timely intervention significantly improves curative potential. However, conventional diagnostic modalities such as imaging and tissue biopsy often lack sensitivity for early-stage disease and are inherently invasive. To address these limitations, we introduce Epi-Liquidomics, defined as the comprehensive profiling of circulating epigenetic alterations including DNA methylation patterns, histone derived nucleosome signatures, chromatin fragmentation landscapes and non-coding RNA cargo to enable non-invasive cancer diagnostics supported by advancing technologies. Emerging preclinical and clinical evidence indicates that tumor associated DNA methylation and cfDNA fragmentation signatures are detectable even in stage I\u2013II cancers, directly supporting their applicability in early disease identification rather than solely conceptual potential. By integrating multi-layered epigenetic signals into liquid biopsy platforms, Epi-Liquidomics enhances cancer detection in low tumor-fraction settings and enables accurate tissue-of-origin prediction, offering advantages over mutation centric genomic assays. Beyond early diagnosis, Epi-Liquidomics provides insights into tumor biology by capturing dynamic regulatory states and microenvironment-associated alterations, facilitating improved risk stratification and longitudinal disease monitoring. This framework supports real-time assessment of therapeutic response and detection of minimal residual disease. Importantly, its current limitations including false-positive rates in population screening, assay standardization, and biological variability underscore the need for rigorous prospective validation before routine clinical implementation. As sequencing technologies and computational tools continue to advance, Epi-Liquidomics holds strong translational potential to refine cancer screening and advance minimally invasive precision oncology.<\/jats:p>","DOI":"10.3389\/freae.2026.1813822","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T22:10:24Z","timestamp":1775772624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Epi-liquidomics: redefining cancer diagnostics through epigenetic profiling"],"prefix":"10.3389","volume":"4","author":[{"given":"Shahper Nazeer","family":"Khan","sequence":"first","affiliation":[{"name":"Integral Centre of Excellence for Interdisciplinary Research (ICEIR), Integral University","place":["Lucknow, India"]},{"name":"Department of Biosciences, Integral University","place":["Lucknow, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Harris","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Integral University","place":["Lucknow, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Guarnera","sequence":"additional","affiliation":[{"name":"Policlinico Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salamatu Tijjani","family":"Isah","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Integral University","place":["Lucknow, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103842","DOI":"10.1016\/j.sjbs.2023.103842","article-title":"Deregulation of TWIST1 expression by promoter methylation in gastrointestinal cancers","volume":"31","author":"Alfahed","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41467-023-35959-6","article-title":"DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation","volume":"14","author":"An","year":"2023","journal-title":"Nat. Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/s41591-023-02605-z","article-title":"Liquid biopsy epigenomic profiling for cancer subtyping","volume":"29","author":"Baca","year":"2023","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2404058121","DOI":"10.1073\/pnas.2404058121","article-title":"Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patterns","volume":"121","author":"Bai","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/annonc\/mdv272","article-title":"Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer","volume":"26","author":"Barault","year":"2015","journal-title":"Ann. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1136\/gutjnl-2016-313372","article-title":"Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer","volume":"67","author":"Barault","year":"2017","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"22580","DOI":"10.1038\/s41598-024-67221-4","article-title":"Nanoparticles as a novel key driver for the isolation and detection of circulating tumour cells","volume":"14","author":"Bashir","year":"2024","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1200\/jco.2025.43.16_suppl.5074","article-title":"Plasma epigenomic profiling to reveal molecular correlates of response and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC)","volume":"43","author":"Berchuck","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1158\/1078-0432.ccr-23-1197","article-title":"OVAPRINT\u2014A cell-free DNA methylation liquid biopsy for the risk assessment of high-grade serous ovarian cancer","volume":"29","author":"Buckley","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1136\/gutjnl-2019-318882","article-title":"Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma","volume":"68","author":"Cai","year":"2019","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100021","DOI":"10.1016\/j.esmoop.2020.100021","article-title":"Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma","volume":"6","author":"Cai","year":"2021","journal-title":"ESMO Open"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/cancers14092317","article-title":"Circulating MIRNAs in Breast Cancer diagnosis and Prognosis","volume":"14","author":"Cardinali","year":"2022","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.7150\/jca.34944","article-title":"DNA methylation biomarkers in stool for early screening of colorectal cancer","volume":"10","author":"Chen","year":"2019","journal-title":"J. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3892\/ol.2021.12563","article-title":"The HOTAIR lncRNA: a remarkable oncogenic promoter in human cancer metastasis","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol. Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1373\/clinchem.2012.191551","article-title":"SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer","volume":"59","author":"Chimonidou","year":"2012","journal-title":"Clin. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/cancers14051310","article-title":"The minimal residual disease using liquid biopsies in hematological malignancies","volume":"14","author":"Colmenares","year":"2022","journal-title":"Cancers"},{"key":"B18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.3390\/ijms26115013","article-title":"Liquid biopsy: the challenges of a revolutionary approach in oncology","volume":"26","author":"Coppola","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"104463","DOI":"10.1016\/j.drudis.2025.104463","article-title":"Quantum intelligence in drug discovery: advancing insights with quantum machine learning","volume":"30","author":"Danishuddin","year":"2025","journal-title":"Drug Discov. Today"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.1038\/s41598-019-47642-2","article-title":"Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients","volume":"9","author":"Estival","year":"2019","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1158\/0008-5472.can-13-3392","article-title":"Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer","volume":"74","author":"Fackler","year":"2014","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1186\/s12885-024-13037-4","article-title":"Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines","volume":"24","author":"Ferrier","year":"2024","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.it.2023.03.005","article-title":"Epigenetic liquid biopsies: a novel putative biomarker in immunology and inflammation","volume":"44","author":"Fox-Fisher","year":"2023","journal-title":"Trends Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/genes10010032","article-title":"Epigenetic biomarkers in Cell-Free DNA and applications in liquid biopsy","volume":"10","author":"Gai","year":"2019","journal-title":"Genes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"849024","DOI":"10.3389\/fonc.2022.849024","article-title":"The diagnostic potential of SHOX2 and RASSF1A DNA methylation in early lung adenocarcinoma","volume":"12","author":"Gao","year":"2022","journal-title":"Front. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1158\/1078-0432.ccr-18-0101","article-title":"Cell-Free DNA modification dynamics in Abiraterone Acetate-Treated Prostate Cancer patients","volume":"24","author":"Gordevi\u010dius","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B29","article-title":"GRAIL and UK government to make galleri multi-cancer early detection blood Test available to patients - GRAIL","author":"Grail","year":"2021","journal-title":"GRAIL"},{"key":"B30","unstructured":"Tissue-Free Test for ctDNA monitoring\n          \n          \n          2025"},{"key":"B31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-med-050522-033624","article-title":"Multi-Cancer Early Detection: the new frontier in cancer early detection","volume":"75","author":"Guerra","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s42003-025-07681-0","article-title":"Double and single stranded detection of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore sequencing","volume":"8","author":"Halliwell","year":"2025","journal-title":"Commun. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.21037\/tcr-2025-272","article-title":"Development and clinical applications of liquid biopsy assays in cancer screening","volume":"14","author":"Han","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2024.01.001","article-title":"Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes","volume":"42","author":"Heeke","year":"2024","journal-title":"Cancer Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13148-016-0286-2","article-title":"Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma","volume":"8","author":"Henriksen","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/ijc.30625","article-title":"Methylated free\u2010circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer","volume":"140","author":"Herbst","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/1078-0432.ccr-16-1371","article-title":"Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum","volume":"23","author":"Hulbert","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1743921","DOI":"10.3389\/frai.2025.1743921","article-title":"Multi-modal AI in precision medicine: integrating genomics, imaging, and EHR data for clinical insights","volume":"8","author":"Khan","year":"2026","journal-title":"Front. Artif. Intell."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12021","DOI":"10.1200\/jco.2018.36.15_suppl.12021","article-title":"Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: the Circulating Cell-free Genome Atlas (CCGA) study","volume":"36","author":"Klein","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-023-01178-3","article-title":"Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing","volume":"15","author":"Lau","year":"2023","journal-title":"Genome Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gkae127","article-title":"Low-input and single-cell methods for Infinium DNA methylation BeadChips","volume":"52","author":"Lee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3748\/wjg.v30.i15.2175","article-title":"Circulating tumor DNA in liquid biopsy: current diagnostic limitation","volume":"30","author":"Liu","year":"2024","journal-title":"World J. Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2147\/cmar.s474241","article-title":"ctDNA SNORD3F hypermethylation is a prognostic indicator in EGFR-TKI-Treated advanced non-small cell lung cancer","volume":"16","author":"Liu","year":"2024","journal-title":"Cancer Manag. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.annonc.2024.08.2348","article-title":"Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies","volume":"36","author":"Liu","year":"2024","journal-title":"Ann. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12885-024-12022-1","article-title":"Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/2767-9764.crc-21-0142","article-title":"Methylated Septin9 (MSEPT9): a promising Blood-Based biomarker for the detection and screening of early-onset colorectal cancer","volume":"2","author":"Loomans-Kropp","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.xgen.2025.100974","article-title":"Urine cf-nucleosomes: a non-invasive window into human physiology and disease","volume":"5","author":"Lotem","year":"2025","journal-title":"Cell Genomics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1002\/ijc.28593","article-title":"Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer","volume":"134","author":"Melson","year":"2013","journal-title":"Int. J. Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"549","DOI":"10.25122\/jml-2024-0322","article-title":"MiRNAs as potential biomarkers in early breast cancer detection: a systematic review","volume":"17","author":"Mihai","year":"2024","journal-title":"J. Med. Life"},{"key":"B52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1057\/s41599-022-01141-4","article-title":"Challenges in large-scale bioinformatics projects","volume":"9","author":"Morrison-Smith","year":"2022","journal-title":"Humanit. Soc. Sci. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-025-03929-y","article-title":"Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults","volume":"23","author":"Nguyen","year":"2025","journal-title":"BMC Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1186\/s12885-015-1832-6","article-title":"Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case\u2013control study","volume":"15","author":"\u00d8rntoft","year":"2015","journal-title":"BMC Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12032-024-02504-4","article-title":"Personalized treatment approach for HER2-positive metastatic breast cancer","volume":"41","author":"Pandey","year":"2024","journal-title":"Med. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/s41388-025-03624-5","article-title":"From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies","volume":"44","author":"Pharo","year":"2025","journal-title":"Oncogene"},{"key":"B57","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1158\/2159-8290.cd-22-0796","article-title":"Extrachromosomal DNA amplification contributes to small cell lung cancer heterogeneity and is associated with worse outcomes","volume":"13","author":"Pongor","year":"2023","journal-title":"Cancer Discov."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1373\/clinchem.2013.221044","article-title":"Validation of a Real-Time PCR\u2013Based qualitative assay for the detection of methylated SEPT9 DNA in human plasma","volume":"60","author":"Potter","year":"2014","journal-title":"Clin. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-024-03026-7","article-title":"Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation","volume":"43","author":"Ren","year":"2024","journal-title":"J. Exp. and Clin. Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/cancers16112001","article-title":"Current challenges of Methylation-Based Liquid biopsies in cancer diagnostics","volume":"16","author":"Rendek","year":"2024","journal-title":"Cancers"},{"key":"B61","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1038\/s41598-024-62061-8","article-title":"Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management","volume":"14","author":"Rosas-Alonso","year":"2024","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13072-025-00595-5","article-title":"Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine","volume":"18","author":"Sahoo","year":"2025","journal-title":"Epigenetics and Chromatin"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/s0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1373\/clinchem.2016.270207","article-title":"Free-Circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: an observational prospective cohort study","volume":"63","author":"Schr\u00f6ck","year":"2017","journal-title":"Clin. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s40291-020-00473-8","article-title":"EPI ProColon\u00ae for Colorectal Cancer Screening: a profile of its use in the USA","volume":"24","author":"Shirley","year":"2020","journal-title":"Mol. Diagnosis and Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/s12967-023-04660-z","article-title":"Liquid-based biomarkers in breast cancer: looking beyond the blood","volume":"21","author":"Shuai","year":"2023","journal-title":"J. Transl. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3892\/ol.2013.1626","article-title":"Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis","volume":"6","author":"Song","year":"2013","journal-title":"Oncol. Lett."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1038\/s41598-017-03321-8","article-title":"The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40364-025-00751-9","article-title":"5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation","volume":"13","author":"Song","year":"2025","journal-title":"Biomark. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3390\/biomedicines10082030","article-title":"MGMT promoter methylation as a prognostic factor in primary glioblastoma: a Single-Institution Observational study","volume":"10","author":"Szylberg","year":"2022","journal-title":"Biomedicines"},{"key":"B71","doi-asserted-by":"publisher","first-page":"117720","DOI":"10.1016\/j.bios.2025.117720","article-title":"CRISPR\/Cas12a-mediated DNAzyme\/split-aptamer cascade for label-free detection of site-specific DNA methylation","volume":"287","author":"Tian","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3390\/cancers17183021","article-title":"Methylation Analyses in liquid biopsy of lung cancer patients: a novel and intriguing approach against resistance to target therapies and immunotherapies","volume":"17","author":"Trombetta","year":"2025","journal-title":"Cancers"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1038\/s41467-019-12714-4","article-title":"Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection","volume":"10","author":"Ulz","year":"2019","journal-title":"Nat. Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"16335","DOI":"10.1038\/s41598-023-43520-0","article-title":"Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphoma","volume":"13","author":"Van Den Ackerveken","year":"2023","journal-title":"Sci. Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"102172","DOI":"10.1016\/j.tranon.2024.102172","article-title":"Potentialities and critical issues of liquid biopsy in clinical practice: an umbrella review","volume":"52","author":"Veronese","year":"2025","journal-title":"Transl. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1520869","DOI":"10.3389\/fonc.2025.1520869","article-title":"Evaluation of an innovative multi-cancer early detection test: high sensitivity and specificity in differentiating cancer, inflammatory conditions, and healthy individuals","volume":"15","author":"Walter","year":"2025","journal-title":"Front. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12885-021-08497-x","article-title":"Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"102630","DOI":"10.1016\/j.jbc.2022.102630","article-title":"Long noncoding RNA HOTAIR regulates the stemness of breast cancer cells via activation of the NF-\u03baB signaling pathway","volume":"298","author":"Wang","year":"2022","journal-title":"J. Biol. Chem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fmolb.2015.00013","article-title":"Methylation of cell-free circulating DNA in the diagnosis of cancer","volume":"2","author":"Warton","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cr.2015.126","article-title":"Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients","volume":"25","author":"Wen","year":"2015","journal-title":"Cell Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13073-017-0499-9","article-title":"Methylation patterns in serum DNA for early identification of disseminated breast cancer","volume":"9","author":"Widschwendter","year":"","journal-title":"Genome Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13073-017-0500-7","article-title":"The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer","volume":"9","author":"Widschwendter","year":"","journal-title":"Genome Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1038\/s41467-024-51529-w","article-title":"Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns","volume":"15","author":"Wong","year":"2024","journal-title":"Nat. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"100718","DOI":"10.1016\/j.bj.2024.100718","article-title":"Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum","volume":"48","author":"Wong","year":"2024","journal-title":"Biomed. J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat. Mater."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e2404709","DOI":"10.1002\/smll.202404709","article-title":"Advances and prospects in liquid biopsy techniques for malignant tumor diagnosis and surveillance","volume":"20","author":"Zhang","year":"2024","journal-title":"Small"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1607548","DOI":"10.3389\/fimmu.2025.1607548","article-title":"Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in stage III-IV colorectal cancer","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Epigenetics and Epigenomics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/freae.2026.1813822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T22:10:25Z","timestamp":1775772625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/freae.2026.1813822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":87,"alternative-id":["10.3389\/freae.2026.1813822"],"URL":"https:\/\/doi.org\/10.3389\/freae.2026.1813822","relation":{},"ISSN":["2813-706X"],"issn-type":[{"value":"2813-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1813822"}}